Thomas Jefferson University

Judith Ross

TitleAssoc Prof CHP
InstitutionThomas Jefferson University
DepartmentNursing - Undergraduate
Address1025 Walnut St.
Philadelphia PA 19107
Phone215-955-1648
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R01NS029857     (ROSS, JUDITH L)Sep 25, 1991 - Jun 30, 2001
    NIH
    ESTROGEN EFFECTS ON COGNITION IN TURNER SYNDROME
    Role: Principal Investigator
    R01NS032531     (ROSS, JUDITH L)Jan 1, 1994 - Dec 31, 2009
    NIH
    Androgen Effects On Cognition In Turner Syndrome
    Role: Principal Investigator
    R01NS042777     (ROSS, JUDITH L)May 17, 2001 - Apr 30, 2008
    NIH
    GENETICS OF COGNITION IN ADULT TURNER SYNDROME
    Role: Principal Investigator
    R01NS050597     (ROSS, JUDITH L)May 1, 2006 - Apr 30, 2013
    NIH
    Androgen effect on motor/cognitive outcome in Klinefelter syndrome
    Role: Principal Investigator
    R21MH109158     (ROBERTS, TIMOTHY P)Apr 11, 2016 - Jun 30, 2019
    NIH
    Structural and Functional Characteristics of XYY - Relationship to ASD
    Role: Co-Principal Investigator
    UG1HD090915     (ROSS, JUDITH L)Sep 21, 2016 - Sep 22, 2016
    NIH
    Delaware Nemours/duPont Hospital for Children Site for the IDeA States Pediatric Clinical Trials Network
    Role: Principal Investigator
    UG1OD024958     (AKINS, ROBERT E;ROSS, JUDITH L)Sep 23, 2016 - Aug 31, 2025
    NIH
    The DE Nemours/duPont Hospital for Children IDeA States Pediatric Clinical Trials Network Site
    Role: Principal Investigator
    R01HD092847     (REISS, ALLAN L ;ROSS, JUDITH L)Aug 17, 2018 - May 31, 2024
    NIH
    Brain and Behavior during Puberty in Klinefelter Syndrome
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Jordan TL, Foland-Ross LC, Wun VL, Ross JL, Reiss AL. Cognition, Academic Achievement, Adaptive Behavior, and Quality of Life in Child and Adolescent Boys with Klinefelter Syndrome. J Dev Behav Pediatr. 2023 09 01; 44(7):e476-e485. PMID: 37696031.
      Citations:    
    2. Davis SM, Teerlink C, Lynch JA, Gorman BR, Pagadala M, Liu A, Panizzon MS, Merritt VC, Genovese G, Pyarajan S, Ross JL, Hauger RL. Prevalence, Morbidity, and Mortality of 1,609 Men with Sex Chromosome Aneuploidy: Results from the Diverse Million Veteran Program Cohort. medRxiv. 2023 Jul 16. PMID: 37502926.
      Citations:    
    3. Lozano Wun V, Foland-Ross LC, Jo B, Green T, Hong D, Ross JL, Reiss AL. Adolescent brain development in girls with Turner syndrome. Hum Brain Mapp. 2023 May 01. PMID: 37126641.
      Citations:    
    4. Jordan TL, Klabunde M, Green T, Hong DS, Ross JL, Jo B, Reiss AL. Longitudinal investigation of cognition, social competence, and anxiety in children and adolescents with Turner syndrome. Horm Behav. 2023 03; 149:105300. PMID: 36640638.
      Citations:    
    5. Shaw JL, Semmens E, Okihiro M, Lewis JL, Hirschfeld M, VanWagoner TM, Stephens L, Easa D, Ross JL, Graham N, Watson SE, Szyld EG, Dillard DA, Pyles LA, Darden PM, Carlson JC, Smith PG, McCulloh RJ, Snowden JN, Adeky SH, Singleton R. Best Practices for Conducting Clinical Trials With Indigenous Children in the United States. Am J Public Health. 2021 09; 111(9):1645-1653. PMID: 34436921.
      Citations:    
    6. Quigley CA, Fechner PY, Geffner ME, Eugster EA, Ross JL, Habiby RL, Ugrasbul F, Rubin K, Travers S, Antalis CJ, Patel HN, Davenport ML. Prevention of Growth Failure in Turner Syndrome: Long-Term Results of Early Growth Hormone Treatment in the "Toddler Turner" Cohort. Horm Res Paediatr. 2021; 94(1-2):18-35. PMID: 34111870.
      Citations:    
    7. Lukowski SL, Padrutt ER, Sarafoglou K, Ross JL, Law JR, Olson RE, Mazzocco MMM. Correction: Variation in early number skills and mathematics achievement: Implications from cognitive profiles of children with or without Turner syndrome. PLoS One. 2021; 16(4):e0250388. PMID: 33848303.
      Citations:    
    8. Vogiatzi MG, Davis SM, Ross JL. Cortical Bone Mass is Low in Boys with Klinefelter Syndrome and Improves with Oxandrolone. J Endocr Soc. 2021 Apr 01; 5(4):bvab016. PMID: 33733020.
      Citations:    
    9. Lukowski SL, Padrutt ER, Sarafoglou K, Ross JL, Law JR, Olson RE, Mazzocco MMM. Variation in early number skills and mathematics achievement: Implications from cognitive profiles of children with or without Turner syndrome. PLoS One. 2020; 15(10):e0239224. PMID: 33006984.
      Citations:    
    10. Davis SM, Bloy L, Roberts TPL, Kowal K, Alston A, Tahsin A, Truxon A, Ross JL. Testicular function in boys with 47,XYY and relationship to phenotype. Am J Med Genet C Semin Med Genet. 2020 06; 184(2):371-385. PMID: 32544298.
      Citations:    
    11. Aksglaede L, Davis SM, Ross JL, Juul A. Minipuberty in Klinefelter syndrome: Current status and future directions. Am J Med Genet C Semin Med Genet. 2020 06; 184(2):320-326. PMID: 32476267.
      Citations:    
    12. Conradt E, Flannery T, Aschner JL, Annett RD, Croen LA, Duarte CS, Friedman AM, Guille C, Hedderson MM, Hofheimer JA, Jones MR, Ladd-Acosta C, McGrath M, Moreland A, Neiderhiser JM, Nguyen RHN, Posner J, Ross JL, Savitz DA, Ondersma SJ, Lester BM. Prenatal Opioid Exposure: Neurodevelopmental Consequences and Future Research Priorities. Pediatrics. 2019 09; 144(3). PMID: 31462446.
      Citations:    
    13. O'Donoghue S, Green T, Ross JL, Hallmayer J, Lin X, Jo B, Huffman LC, Hong DS, Reiss AL. Brain Development in School-Age and Adolescent Girls: Effects of Turner Syndrome, Estrogen Therapy, and Genomic Imprinting. Biol Psychiatry. 2020 01 15; 87(2):113-122. PMID: 31561860.
      Citations:    
    14. Matsuzaki J, Bloy L, Blaskey L, Miller J, Kuschner ES, Ku M, Dipiero M, Airey M, Edgar JC, Embick D, Ross JL, Roberts TPL. Abnormal Auditory Mismatch Fields in Children and Adolescents with 47,XYY Syndrome. Dev Neurosci. 2019; 41(1-2):123-131. PMID: 31280271.
      Citations:    
    15. Child CJ, Quigley CA, Cutler GB, Moore WV, Wintergerst KA, Ross JL, Rosenfeld RG, Blum WF. Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational Study. Horm Res Paediatr. 2019; 91(4):241-251. PMID: 31185471.
      Citations:    
    16. Ross JL, Bloy L, Roberts TPL, Miller J, Xing C, Silverman LA, Zinn AR. Y chromosome gene copy number and lack of autism phenotype in a male with an isodicentric Y chromosome and absent NLGN4Y expression. Am J Med Genet B Neuropsychiatr Genet. 2019 10; 180(7):471-482. PMID: 31161682.
      Citations:    
    17. Edgar JC, Dipiero M, McBride E, Green HL, Berman J, Ku M, Liu S, Blaskey L, Kuschner E, Airey M, Ross JL, Bloy L, Kim M, Koppers S, Gaetz W, Schultz RT, Roberts TPL. Abnormal maturation of the resting-state peak alpha frequency in children with autism spectrum disorder. Hum Brain Mapp. 2019 08 01; 40(11):3288-3298. PMID: 30977235.
      Citations:    
    18. Bullinger M, Bloemeke J, Mericq V, Sommer R, Gaete X, Ross JL, Yu YM, Permuy J, Gagliardi P, Damaso YL, Mauras N. Quality of Life in Adolescent Boys with Idiopathic Short Stature: Positive Impact of Growth Hormone and Aromatase Inhibitors. Horm Res Paediatr. 2018; 90(6):381-392. PMID: 30820008.
      Citations:    
    19. Foland-Ross LC, Ross JL, Reiss AL. Androgen treatment effects on hippocampus structure in boys with Klinefelter syndrome. Psychoneuroendocrinology. 2019 02; 100:223-228. PMID: 30388596.
      Citations:    
    20. Pf?ffle R, Land C, Sch?nau E, Holterhus PM, Ross JL, Piras de Oliveira C, Child CJ, Benabbad I, Jia N, Jung H, Blum WF. Growth Hormone Treatment for Short Stature in the USA, Germany and France: 15 Years of Surveillance in the Genetics and Neuroendocrinology of Short-Stature International Study (GeNeSIS). Horm Res Paediatr. 2018; 90(3):169-180. PMID: 30199857.
      Citations:    
    21. Davis SM, Lahlou N, Cox-Martin M, Kowal K, Zeitler PS, Ross JL. Oxandrolone Treatment Results in an Increased Risk of Gonadarche in Prepubertal Boys With Klinefelter Syndrome. J Clin Endocrinol Metab. 2018 09 01; 103(9):3449-3455. PMID: 29931143.
      Citations:    
    22. Pierce JS, Aroian K, Caldwell C, Ross JL, Lee JM, Schifano E, Novotny R, Tamayo A, Wysocki T. The Ups and Downs of Parenting Young Children With Type 1 Diabetes: A Crowdsourcing Study. J Pediatr Psychol. 2017 09 01; 42(8):846-860. PMID: 28369409.
      Citations:    
    23. Ross JL, Kushner H, Kowal K, Bardsley M, Davis S, Reiss AL, Tartaglia N, Roeltgen D. Androgen Treatment Effects on Motor Function, Cognition, and Behavior in Boys with Klinefelter Syndrome. J Pediatr. 2017 06; 185:193-199.e4. PMID: 28285751.
      Citations:    
    24. Davis SM, Cox-Martin MG, Bardsley MZ, Kowal K, Zeitler PS, Ross JL. Effects of Oxandrolone on Cardiometabolic Health in Boys With Klinefelter Syndrome: A Randomized Controlled Trial. J Clin Endocrinol Metab. 2017 01 01; 102(1):176-184. PMID: 27802097.
      Citations:    
    25. Benabbad I, Rosilio M, Child CJ, Carel JC, Ross JL, Deal CL, Drop SL, Zimmermann AG, Jia N, Quigley CA, Blum WF. Safety Outcomes and Near-Adult Height Gain of Growth Hormone-Treated Children with SHOX Deficiency: Data from an Observational Study and a Clinical Trial. Horm Res Paediatr. 2017; 87(1):42-50. PMID: 28002818.
      Citations:    
    26. Mauras N, Ross JL, Gagliardi P, Yu YM, Hossain J, Permuy J, Damaso L, Merinbaum D, Singh RJ, Gaete X, Mericq V. Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys with Idiopathic, Short Stature. J Clin Endocrinol Metab. 2016 12; 101(12):4984-4993. PMID: 27710241.
      Citations:    
    27. Benito-Sanz S, Belinchon-Mart?nez A, Aza-Carmona M, de la Torre C, Huber C, Gonz?lez-Casado I, Ross JL, Thomas NS, Zinn AR, Cormier-Daire V, Heath KE. Identification of 15 novel partial SHOX deletions and 13 partial duplications, and a review of the literature reveals intron 3 to be a hotspot region. J Hum Genet. 2017 Feb; 62(2):229-234. PMID: 27604558.
      Citations:    
    28. Wysocki T, Hirschfeld F, Miller L, Izenberg N, Dowshen SA, Taylor A, Milkes A, Shinseki MT, Bejarano C, Kozikowski C, Kowal K, Starr-Ashton P, Ross JL, Kummer M, Carakushansky M, Lyness D, Brinkman W, Pierce J, Fiks A, Christofferson J, Rafalko J, Lawson ML. Consideration of Insulin Pumps or Continuous Glucose Monitors by Adolescents With Type 1 Diabetes and Their Parents: Stakeholder Engagement in the Design of Web-Based Decision Aids. Diabetes Educ. 2016 08; 42(4):395-407. PMID: 27150606.
      Citations:    
    29. Davis SM, Rogol AD, Ross JL. Testis Development and Fertility Potential in Boys with Klinefelter Syndrome. Endocrinol Metab Clin North Am. 2015 Dec; 44(4):843-65. PMID: 26568497.
      Citations:    
    30. Lee PA, Ross JL, Pedersen BT, Kotnik P, Germak JA, Christesen HT. Noonan syndrome and Turner syndrome patients respond similarly to 4 years' growth-hormone therapy: longitudinal analysis of growth-hormone-na?ve patients enrolled in the NordiNet? International Outcome Study and the ANSWER Program. Int J Pediatr Endocrinol. 2015; 2015(1):17. PMID: 26351466.
      Citations:    
    31. Ross JL, Lee PA, Gut R, Germak J. Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years. Growth Horm IGF Res. 2015 Dec; 25(6):286-93. PMID: 26363846.
      Citations:    
    32. Child CJ, Kalifa G, Jones C, Ross JL, Rappold GA, Quigley CA, Zimmermann AG, Garding G, Cutler GB, Blum WF. Radiological Features in Patients with Short Stature Homeobox-Containing (SHOX) Gene Deficiency and Turner Syndrome before and after 2 Years of GH Treatment. Horm Res Paediatr. 2015; 84(1):14-25. PMID: 25967354.
      Citations:    
    33. Ross JL, Lee PA, Gut R, Germak J. Increased height standard deviation scores in response to growth hormone therapy to near-adult height in older children with delayed skeletal maturation: results from the ANSWER Program. Int J Pediatr Endocrinol. 2015; 2015(1):1. PMID: 25904938.
      Citations:    
    34. McCulloch MA, Mauras N, Canas JA, Hossain J, Sikes KM, Damaso LC, Redheuil A, Ross JL, Gidding SS. Magnetic resonance imaging measures of decreased aortic strain and distensibility are proportionate to insulin resistance in adolescents with type 1 diabetes mellitus. Pediatr Diabetes. 2015 Mar; 16(2):90-7. PMID: 25524487.
      Citations:    
    35. Canas JA, Ross JL, Taboada MV, Sikes KM, Damaso LC, Hossain J, Caulfield MP, Gidding SS, Mauras N. A randomized, double blind, placebo-controlled pilot trial of the safety and efficacy of atorvastatin in children with elevated low-density lipoprotein cholesterol (LDL-C) and type 1 diabetes. Pediatr Diabetes. 2015 Mar; 16(2):79-89. PMID: 25418907.
      Citations:    
    36. Quigley CA, Wan X, Garg S, Kowal K, Cutler GB, Ross JL. Effects of low-dose estrogen replacement during childhood on pubertal development and gonadotropin concentrations in patients with Turner syndrome: results of a randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab. 2014 Sep; 99(9):E1754-64. PMID: 24762109.
      Citations:    
    37. Quintero AI, Beaton EA, Harvey DJ, Ross JL, Simon TJ. Common and specific impairments in attention functioning in girls with chromosome 22q11.2 deletion, fragile X or Turner syndromes. J Neurodev Disord. 2014 Mar 14; 6(1):5. PMID: 24628892.
      Citations:    
    38. Rogol AD, Swerdloff RS, Reiter EO, Ross JL, ZumBrunnen TL, Pratt GA, Brennan JJ, Benesh J, Kan-Dobrosky N, Miller MG. A multicenter, open-label, observational study of testosterone gel (1%) in the treatment of adolescent boys with klinefelter syndrome or anorchia. J Adolesc Health. 2014 Jan; 54(1):20-5. PMID: 24035132.
      Citations:    
    39. Bardsley MZ, Kowal K, Levy C, Gosek A, Ayari N, Tartaglia N, Lahlou N, Winder B, Grimes S, Ross JL. 47,XYY syndrome: clinical phenotype and timing of ascertainment. J Pediatr. 2013 Oct; 163(4):1085-94. PMID: 23810129.
      Citations:    
    40. Blum WF, Ross JL, Zimmermann AG, Quigley CA, Child CJ, Kalifa G, Deal C, Drop SL, Rappold G, Cutler GB. GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial. J Clin Endocrinol Metab. 2013 Aug; 98(8):E1383-92. PMID: 23720786.
      Citations:    
    41. Olney RC, Prickett TC, Espiner EA, Ross JL. C-Type Natriuretic Peptide (CNP) levels are altered in boys with Klinefelter syndrome. J Clin Endocrinol Metab. 2012 Nov; 97(11):4206-11. PMID: 22962429.
      Citations:    
    42. Ross JL, Roeltgen DP, Kushner H, Zinn AR, Reiss A, Bardsley MZ, McCauley E, Tartaglia N. Behavioral and social phenotypes in boys with 47,XYY syndrome or 47,XXY Klinefelter syndrome. Pediatrics. 2012 Apr; 129(4):769-78. PMID: 22412026.
      Citations:    
    43. Lahlou N, Fennoy I, Ross JL, Bouvattier C, Roger M. Clinical and hormonal status of infants with nonmosaic XXY karyotype. Acta Paediatr. 2011 Jun; 100(6):824-9. PMID: 21429009.
      Citations:    
    44. Ross JL, Quigley CA, Cao D, Feuillan P, Kowal K, Chipman JJ, Cutler GB. Growth hormone plus childhood low-dose estrogen in Turner's syndrome. N Engl J Med. 2011 Mar 31; 364(13):1230-42. PMID: 21449786.
      Citations:    
    45. Bardsley MZ, Falkner B, Kowal K, Ross JL. Insulin resistance and metabolic syndrome in prepubertal boys with Klinefelter syndrome. Acta Paediatr. 2011 Jun; 100(6):866-70. PMID: 21251059.
      Citations:    
    46. Cabrol S, Ross JL, Fennoy I, Bouvattier C, Roger M, Lahlou N. Assessment of Leydig and Sertoli cell functions in infants with nonmosaic Klinefelter syndrome: insulin-like peptide 3 levels are normal and positively correlated with LH levels. J Clin Endocrinol Metab. 2011 Apr; 96(4):E746-53. PMID: 21307139.
      Citations:    
    47. Zeger MP, Shah K, Kowal K, Cutler GB, Kushner H, Ross JL. Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome. Horm Res Paediatr. 2011; 75(1):38-46. PMID: 20733274.
      Citations:    
    48. Beaton EA, Stoddard J, Lai S, Lackey J, Shi J, Ross JL, Simon TJ. Atypical functional brain activation during a multiple object tracking task in girls with Turner syndrome: neurocorrelates of reduced spatiotemporal resolution. Am J Intellect Dev Disabil. 2010 Mar; 115(2):140-56. PMID: 20441384.
      Citations:    
    49. Ross JL, Mazzocco MM, Kushner H, Kowal K, Cutler GB, Roeltgen D. Effects of treatment with oxandrolone for 4 years on the frequency of severe arithmetic learning disability in girls with Turner syndrome. J Pediatr. 2009 Nov; 155(5):714-20. PMID: 19643440.
      Citations:    
    50. Blum WF, Cao D, Hesse V, Fricke-Otto S, Ross JL, Jones C, Quigley CA, Binder G. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome. Horm Res. 2009; 71(3):167-72. PMID: 19188742.
      Citations:    
    51. Ross JL, Zeger MP, Kushner H, Zinn AR, Roeltgen DP. An extra X or Y chromosome: contrasting the cognitive and motor phenotypes in childhood in boys with 47,XYY syndrome or 47,XXY Klinefelter syndrome. Dev Disabil Res Rev. 2009; 15(4):309-17. PMID: 20014371.
      Citations:    
    52. Zinn AR, Kushner H, Ross JL. EFHC2 SNP rs7055196 is not associated with fear recognition in 45,X Turner syndrome. Am J Med Genet B Neuropsychiatr Genet. 2008 Jun 05; 147B(4):507-9. PMID: 17948898.
      Citations:    
    53. Ross JL, Roeltgen DP, Stefanatos G, Benecke R, Zeger MP, Kushner H, Ramos P, Elder FF, Zinn AR. Cognitive and motor development during childhood in boys with Klinefelter syndrome. Am J Med Genet A. 2008 Mar 15; 146A(6):708-19. PMID: 18266239.
      Citations:    
    54. Zeger MP, Zinn AR, Lahlou N, Ramos P, Kowal K, Samango-Sprouse C, Ross JL. Effect of ascertainment and genetic features on the phenotype of Klinefelter syndrome. J Pediatr. 2008 May; 152(5):716-22. PMID: 18410780.
      Citations:    
    55. Davenport ML, Crowe BJ, Travers SH, Rubin K, Ross JL, Fechner PY, Gunther DF, Liu C, Geffner ME, Thrailkill K, Huseman C, Zagar AJ, Quigley CA. Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial. J Clin Endocrinol Metab. 2007 Sep; 92(9):3406-16. PMID: 17595258.
      Citations:    
    56. Zinn AR, Roeltgen D, Stefanatos G, Ramos P, Elder FF, Kushner H, Kowal K, Ross JL. A Turner syndrome neurocognitive phenotype maps to Xp22.3. Behav Brain Funct. 2007 May 21; 3:24. PMID: 17517138.
      Citations:    
    57. Campos-Barros A, Benito-Sanz S, Ross JL, Zinn AR, Heath KE. Compound heterozygosity of SHOX-encompassing and downstream PAR1 deletions results in Langer mesomelic dysplasia (LMD). Am J Med Genet A. 2007 May 01; 143A(9):933-8. PMID: 17394206.
      Citations:    
    58. Rappold G, Blum WF, Shavrikova EP, Crowe BJ, Roeth R, Quigley CA, Ross JL, Niesler B. Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency. J Med Genet. 2007 May; 44(5):306-13. PMID: 17182655.
      Citations:    
    59. Blum WF, Crowe BJ, Quigley CA, Jung H, Cao D, Ross JL, Braun L, Rappold G. Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial. J Clin Endocrinol Metab. 2007 Jan; 92(1):219-28. PMID: 17047016.
      Citations:    
    60. Fechner PY, Davenport ML, Qualy RL, Ross JL, Gunther DF, Eugster EA, Huseman C, Zagar AJ, Quigley CA. Differences in follicle-stimulating hormone secretion between 45,X monosomy Turner syndrome and 45,X/46,XX mosaicism are evident at an early age. J Clin Endocrinol Metab. 2006 Dec; 91(12):4896-902. PMID: 16968797.
      Citations:    
    61. Mazzocco MM, Thompson L, Sudhalter V, Belser RC, Lesniak-Karpiak K, Ross JL. Language use in females with fragile X or Turner syndrome during brief initial social interactions. J Dev Behav Pediatr. 2006 Aug; 27(4):319-28. PMID: 16906008.
      Citations:    
    62. Schmidt PJ, Cardoso GM, Ross JL, Haq N, Rubinow DR, Bondy CA. Shyness, social anxiety, and impaired self-esteem in Turner syndrome and premature ovarian failure. JAMA. 2006 Mar 22; 295(12):1374-6. PMID: 16551707.
      Citations:    
    63. Russell HF, Wallis D, Mazzocco MM, Moshang T, Zackai E, Zinn AR, Ross JL, Muenke M. Increased prevalence of ADHD in Turner syndrome with no evidence of imprinting effects. J Pediatr Psychol. 2006 Oct; 31(9):945-55. PMID: 16524959.
      Citations:    
    64. Zinn AR, Ramos P, Ross JL. A second recombination hotspot associated with SHOX deletions. Am J Hum Genet. 2006 Mar; 78(3):523-5. PMID: 16572514.
      Citations:    
    65. Ross JL. Effects of growth hormone on cognitive function. Horm Res. 2005; 64 Suppl 3:89-94. PMID: 16439850.
      Citations:    
    66. Ross JL, Kowal K, Quigley CA, Blum WF, Cutler GB, Crowe B, Hovanes K, Elder FF, Zinn AR. The phenotype of short stature homeobox gene (SHOX) deficiency in childhood: contrasting children with Leri-Weill dyschondrosteosis and Turner syndrome. J Pediatr. 2005 Oct; 147(4):499-507. PMID: 16227037.
      Citations:    
    67. Ross JL, Samango-Sprouse C, Lahlou N, Kowal K, Elder FF, Zinn A. Early androgen deficiency in infants and young boys with 47,XXY Klinefelter syndrome. Horm Res. 2005; 64(1):39-45. PMID: 16088206.
      Citations:    
    68. Zinn AR, Ramos P, Elder FF, Kowal K, Samango-Sprouse C, Ross JL. Androgen receptor CAGn repeat length influences phenotype of 47,XXY (Klinefelter) syndrome. J Clin Endocrinol Metab. 2005 Sep; 90(9):5041-6. PMID: 15956082.
      Citations:    
    69. Quigley CA, Gill AM, Crowe BJ, Robling K, Chipman JJ, Rose SR, Ross JL, Cassorla FG, Wolka AM, Wit JM, Rekers-Mombarg LT, Cutler GB. Safety of growth hormone treatment in pediatric patients with idiopathic short stature. J Clin Endocrinol Metab. 2005 Sep; 90(9):5188-96. PMID: 15899952.
      Citations:    
    70. Ross JL, Sandberg DE, Rose SR, Leschek EW, Baron J, Chipman JJ, Cassorla FG, Quigley CA, Crowe BJ, Roberts K, Cutler GB. Psychological adaptation in children with idiopathic short stature treated with growth hormone or placebo. J Clin Endocrinol Metab. 2004 Oct; 89(10):4873-8. PMID: 15472178.
      Citations:    
    71. Courcoutsakis NA, Patronas NJ, Cassarino D, Griffin K, Keil M, Ross JL, Carney JA, Stratakis CA. Hypodense nodularity on computed tomography: novel imaging and pathology of micronodular adrenocortical hyperplasia associated with myelolipomatous changes. J Clin Endocrinol Metab. 2004 Aug; 89(8):3737-8. PMID: 15292298.
      Citations:    
    72. Leppig KA, Sybert VP, Ross JL, Cunniff C, Trejo T, Raskind WH, Disteche CM. Phenotype and X inactivation in 45,X/46,X,r(X) cases. Am J Med Genet A. 2004 Jul 30; 128A(3):276-84. PMID: 15216549.
      Citations:    
    73. Leschek EW, Rose SR, Yanovski JA, Troendle JF, Quigley CA, Chipman JJ, Crowe BJ, Ross JL, Cassorla FG, Blum WF, Cutler GB, Baron J. Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2004 Jul; 89(7):3140-8. PMID: 15240584.
      Citations:    
    74. Ross JL, Stefanatos GA, Kushner H, Bondy C, Nelson L, Zinn A, Roeltgen D. The effect of genetic differences and ovarian failure: intact cognitive function in adult women with premature ovarian failure versus turner syndrome. J Clin Endocrinol Metab. 2004 Apr; 89(4):1817-22. PMID: 15070950.
      Citations:    
    75. Boycott KM, Parslow MI, Ross JL, Miller IP, Bech-Hansen NT, MacLeod PM. A familial contiguous gene deletion syndrome at Xp22.3 characterized by severe learning disabilities and ADHD. Am J Med Genet A. 2003 Oct 01; 122A(2):139-47. PMID: 12955766.
      Citations:    
    76. Lesniak-Karpiak K, Mazzocco MM, Ross JL. Behavioral assessment of social anxiety in females with Turner or fragile X syndrome. J Autism Dev Disord. 2003 Feb; 33(1):55-67. PMID: 12708580.
      Citations:    
    77. Ross JL, Bellus G, Scott CI, Abboudi J, Grigelioniene G, Zinn AR. Mesomelic and rhizomelic short stature: The phenotype of combined Leri-Weill dyschondrosteosis and achondroplasia or hypochondroplasia. Am J Med Genet A. 2003 Jan 01; 116A(1):61-5. PMID: 12476453.
      Citations:    
    78. Brown WE, Kesler SR, Eliez S, Warsofsky IS, Haberecht M, Patwardhan A, Ross JL, Neely EK, Zeng SM, Yankowitz J, Reiss AL. Brain development in Turner syndrome: a magnetic resonance imaging study. Psychiatry Res. 2002 Dec 30; 116(3):187-96. PMID: 12477602.
      Citations:    
    79. Zinn AR, Wei F, Zhang L, Elder FF, Scott CI, Marttila P, Ross JL. Complete SHOX deficiency causes Langer mesomelic dysplasia. Am J Med Genet. 2002 Jun 15; 110(2):158-63. PMID: 12116254.
      Citations:    
    Ross's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (321)
    Explore
    _
    Co-Authors (5)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _